Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes.

ABSTRACT:

Objective

To evaluate the efficacy and safety of a digital therapeutic application (app) delivering cognitive behavioral therapy (CBT) designed to improve glycemic control in patients with type 2 diabetes.

Research design and methods

Adults with type 2 diabetes and an HbA1c of 7 to <11% were randomly assigned to receive access to a digital therapeutic app delivering CBT (BT-001) or a control app, both on top of standard of care management. CBT is an established form of psychological treatment that endeavors to identify and change unhelpful thinking patterns. The primary study end point was treatment group difference in mean HbA1c change from baseline to 90 days.

Results

Among 669 randomly assigned subjects who completed app onboarding, the mean age was 58 years, BMI 3

SUBMITTER: Hsia J 

PROVIDER: S-EPMC9862458 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature